Home Alzheimer’s Disease Clinical Pathways Lead to Reduction in Spending Within the Oncology Care Model

Clinical Pathways Lead to Reduction in Spending Within the Oncology Care Model

In a study, published in the Journal of Clinical Oncology: Oncology Practice, researchers demonstrated that the reduction of drug spending by using value-based clinical pathways to optimize chemotherapy utilization is possible and can increase the chances of a practice’s success within the Oncology Care Model (OCM). 

Researchers indicated that misguided perceptions that drug prices are outside the control of oncologists has led to many OCM participants focusing their efforts on other areas to reduce costs, such as reducing preventable emergency department visits and hospital admissions.

“This perception fails to account for the documented success value-based clinical pathways have had in reducing drug spend with no change in clinical outcomes,” the authors wrote. “Given the high percentage of the total episode cost that drug spend accounts for, small improvements in…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

please help us fundraise (501c3 non-profit) : braincancer

I work with OurBrainBank, a start-up non-profit dedicated to moving glioblastoma from terminal to treatable, powered by patients.We're a registered 501c3 non-profit in the...

Cancer and Mental Health Re-post : braincancer

Hello!I would like to thank everyone who participated in my survey these past few months! I received a tremendous response and I truly, truly...

I put my feelings in music. : braincancer

Song LinkHi amigos. My 2year old son has been battling cancer for nearly 6 months and this song is just a expression of my...

Recent Comments